(LOGC) Logicbio Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Logicbio Therapeutics | (LOGC) share price targets
Complete technical analysis of Logicbio Therapeutics (LOGC) by charts plus indicators, forecast predictions and share price targets for Logicbio Therapeutics (LOGC)
Logicbio Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-01-13 View latest technical analysis
10 day averaged volume of Logicbio Therapeutics is 217222
| Date | Daily Closing Price | Open | High | Low | Volume |
| 13 Mon Jan 2025 | 6.63 | 6.69 | 6.81 | 6.51 | 0.581 times |
| 10 Fri Jan 2025 | 6.75 | 6.83 | 6.99 | 6.59 | 1.074 times |
| 08 Wed Jan 2025 | 6.93 | 7.02 | 7.07 | 6.89 | 0.627 times |
| 08 Wed Jan 2025 | 6.93 | 7.02 | 7.07 | 6.89 | 0.627 times |
| 07 Tue Jan 2025 | 7.08 | 7.11 | 7.22 | 6.96 | 0.541 times |
| 06 Mon Jan 2025 | 7.11 | 7.30 | 7.37 | 7.00 | 1.046 times |
| 03 Fri Jan 2025 | 7.29 | 6.95 | 7.41 | 6.95 | 1.404 times |
| 02 Thu Jan 2025 | 6.93 | 7.08 | 7.11 | 6.85 | 0.99 times |
| 31 Tue Dec 2024 | 7.03 | 7.02 | 7.12 | 6.84 | 1.039 times |
| 30 Mon Dec 2024 | 7.08 | 7.00 | 7.11 | 6.66 | 1.467 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 6.7, but if it comes above 6.7, then a intra day buy could be more profitable.
If you take a sell trade below 6.7, then use 6.7 as stoploss and 6.4 as target. However if you take a buy trade in stock , then use 6.7 as stoploss and 6.92 as target.
Share price targets for Logicbio Therapeutics (LOGC)
| Target Type | Value |
| Downside Target | 5.12 |
| Downside Target | 5.35 |
| Downside Target | 5.57 |
| Downside Target | 6.03 |
| Downside Target | 6.43 |
| Upside Target | 7.04 |
| Upside Target | 7.07 |
| Upside Target | 7.25 |
| Upside Target | 7.37 |
| Upside Target | 7.41 |
| Upside Target | 8.21 |
Intraday share price targets for Logicbio Therapeutics (LOGC)
| Target Type | Value |
| Downside Intraday Target | 6.49 |
| Downside Intraday Target | 6.35 |
| Upside Intraday Target | 6.79 |
| Upside Intraday Target | 6.95 |
| Upside Intraday Target | 6.65 |
Weekly technical analysis of Logicbio Therapeutics (LOGC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 13 Mon Jan 2025 | 6.63 | 6.69 | 6.81 | 6.51 | 0.342 times |
| 10 Fri Jan 2025 | 6.75 | 7.02 | 7.07 | 6.59 | 0.768 times |
| 08 Wed Jan 2025 | 6.93 | 7.30 | 7.37 | 6.89 | 0.452 times |
| 03 Fri Jan 2025 | 7.29 | 7.00 | 7.41 | 6.66 | 1.569 times |
| 27 Fri Dec 2024 | 7.02 | 6.69 | 7.04 | 6.51 | 0.505 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Logicbio Therapeutics (LOGC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 13 Mon Jan 2025 | 6.63 | 7.08 | 7.41 | 6.51 | 0.399 times |
| 31 Tue Dec 2024 | 7.03 | 7.98 | 8.21 | 6.43 | 0.702 times |
| 26 Tue Nov 2024 | 7.10 | 6.47 | 7.25 | 6.03 | 0.748 times |
| 31 Thu Oct 2024 | 6.49 | 5.45 | 6.72 | 5.35 | 1.571 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Logicbio Therapeutics (LOGC)
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Logicbio Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Logicbio Therapeutics in short term but the sell signal is initial and weak.
Logicbio Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Logicbio Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Logicbio Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.01 and Logicbio Therapeutics (LOGC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Logicbio Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Logicbio Therapeutics in short term but the sell signal is initial and weak.
Logicbio Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Logicbio Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Logicbio Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.01 and Logicbio Therapeutics (LOGC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.